Errors Involving Patients Receiving Intrathecal Chemotherapy

REFERENCES

• Kwong YL, Yeung DY, Chan JC. Intrathecal chemotherapy for hema-tologic malignancies: drugs and toxicities. Ann Hematol. 2009; 88 (3): 193–201.
   PubMed Web of Science ®Google Scholar
• Ruggiero A, Conter V, Milani M, Biagi E, Lazzareschi I, Sparano P, Riccardi R. Intrathecal chemotherapy with antineoplastic agents in children. Paediatr Drugs. 2001; 3 (4): 237–246.
   PubMed Web of Science ®Google Scholar
• Pui CH, Howard SC. Current management and challenges of malignant disease in the CNS in paediatric leukaemia. Lancet Oncol. 2008; 9: 257–268.
   PubMed Web of Science ®Google Scholar
• Erdlenbruch B, Lakomek M, Bjerre L. Chemotherapy errors in oncol-ogy. Med Ped Oncol 2002; 38: 353–356.
   PubMedGoogle Scholar
• Shepherd DA, Steuber CP,Starling KA, Fernbach DJ. Accidental in-trathecal administration of vincristine. Med Ped Oncol. 1978; 5: 85–88.
   PubMedGoogle Scholar
• Williams ME, Walker AN, Bracikowski JP, Gamer L, Wilson KD, Car-penter JT. Ascending myeloencephalopathy due to intrathecal vincristine sulfate. A fatal chemotherapeutic error. Cancer. 1983; 51 (11): 2041–2047.
   Google Scholar
• Gaidys WG, Dickerman JD, Walters CL, Young PC. Intrathecal vin-cristine. Report of a fatal case despite CNS washout. Cancer. 1983; 52 (5): 799–801.
   Google Scholar
• Erdlenbruch B, Lakomek M, Bjerre LM. Editorial: chemotherapy errors in oncology. Med Pediatr Oncol. 2002; 38 (5): 353–356.
   PubMedGoogle Scholar
• Wong ICK, Ghaleb M, Dean Franklin B. Barber N. Incidence and na-ture of dosing errors in paediatric medications. A systematic review. Drug Safety 2004; 27 (9): 661–670 .
   PubMed Web of Science ®Google Scholar
• Trinkle R, Wu JK. Errors involving pediatric patients receiving chemotherapy: a literature review. Med Pediatr Oncol. 1996; 26 (5): 344-351. O'Marcaigh AS, Johnson CM, Smithson WA, Patterson MC, Wide-mann BC, Adamson PC, et al. Successful treatment of intrathecal methotrex-ate overdose by using ventriculolumhar perfusion and intrathecal instillation of carhxypeptidase G2. Mayo Clin Proc 1996; 71: 161–165.
   Google Scholar
• Jardine LF, Ingram LC, Bleyer WA. Intrathecal leucovorin after in-trathecal methotrexate overdose. J Pediatr Hematol Oncol 1996; 18: 302–304.
   PubMed Web of Science ®Google Scholar
• Jakobson AM, Kreuger A, Mortimer O, Henningsson S, Seidel, Moe PJ. Cerebrospinal fluid exchange after intrathecal methotrexate overdose. A report of two cases. Acta Paediatr 1992; 81: 359–366.
   PubMed Web of Science ®Google Scholar
• Spiegel RJ, Cooper PR, Blum RI-I, Speyer JL, McBride D, Mangiardi J. Treatment of massive intrathecal methotrexate overdose by ventricu-lolumhar perfusion. N Engl J Med 1984; 311: 386–388.
   PubMed Web of Science ®Google Scholar
• Ettinger LJ. Pharmacokinetics and biochemical effects of a fatal in-trathecal methotrexate overdose. Cancer 1982; 50: 444–450.
   PubMed Web of Science ®Google Scholar
• Addiego E, Ridgway D, Bleyer WA. The acute management of in-trathecal methotrexate overdose: pharmacologic rationale and guidelines. J Pediatr 1981; 98: 825–828.
   PubMed Web of Science ®Google Scholar
• Lampkin BC, Higgins GR, Hammond D. Absence of neurotoxicity fol-lowing massive intrathecal administration of methotrexate. Case report. Can-cer. 1967; 20 (10): 1780–1781.
   Google Scholar
• Ettinger LI, Freeman Al, Creaven PJ. Intrathecal methotrexate over-dose without neurotoxicity: case report and literature review. Cancer 1978; 41: 1270–1273.
   PubMed Web of Science ®Google Scholar
• Malbora B, Ozyurek E, Kocum Al, Ozbek N. Delayed recognition of intrathecal methotrexate overdose. Pediatr Hematol Oncol. 2009; 31 (5): 352–354.
   Web of Science ®Google Scholar
• Lee AC, Wong KW, Fong KW, So KT. Intrathecal methotrexate over-dose. Acta Paediatr. 1997; 86 (4): 434–437.
   PubMed Web of Science ®Google Scholar
• Finkelstein Y, Zevin S, Heyd J, et al. Emergency treatment of life-threatening intrathecal methotrexate overdose. Neurotoxicology. 2004; 25: 407–410.
   PubMed Web of Science ®Google Scholar
• Widemann BC, Balis FM, Shalabi A, et al. Treatment of accidental in-trathecal methotrexate overdose with intrathecal carboxypeptidase G2. J Natl Cancer Inst. 2004; 96: 1557-1559.
   Google Scholar
• Riva L, Conter V, Rizzari C, et al. Successful treatment of intrathecal methotrexate overdose with folinic acid rescue: a case report. Acta Paediatr. 1999; 88: 780–782.
   PubMed Web of Science ®Google Scholar
• Gosselin S, Isbister GK. Treatment of accidental intrathecal methotrex-ate overdose. J Natl Cancer Inst. 2005; 97: 609–610.
   PubMedGoogle Scholar
• Lafolie P, Liliemark J, Björk O, Aman J, Wranne L, Peterson C. Ex-change of cerebrospinal fluid in accidental intrathecal overdose of cytara-bine. Med Toxicol Adverse Drug Exp. 1988; 3 (3): 248–252.
   PubMedGoogle Scholar
• Gilbar PJ, Carrington CV. Preventing intrathecal administration of vin-cristine. Med J Aust 2004; 181: 464.
   PubMed Web of Science ®Google Scholar
• Williams ME, Walker AN, Bracikowski JP, Garner L, Wilson KD, Car-penter JT. Ascending myeloencephalopathy due to intrathecal vincristine sulfate. A fatal chemotherapeutic error. Cancer. 1983; 51 (11): 2041–2047.
   Google Scholar
• Kwack EK, Kim DJ, Park TI, Cho KR, Kwon IH, Sohn YK. Neural tox-icity induced by accidental intrathecal vincristine administration. J Korean Med Sci. 1999; 14 (6): 688–692.
   PubMed Web of Science ®Google Scholar
• Manelis J, Freundlich E, Ezekiel E, Doron J. Accidental intrathecal yin-cristine administration. J Neurol 1982; 228: 209–213.
   PubMed Web of Science ®Google Scholar
• Schochet SS Jr, Lampert PW, Earle KM. Neuronal changes induced by intrathecal vincristine sulfate. J Neuropathol Exp Neurol. 1968; 27: 645–658.
   PubMed Web of Science ®Google Scholar
• Qweider M, Gilsbach JM, Rohde V. Inadvertent intrathecal vincristine administration: a neurosurgical emergency. Case report. J Neurosurg Spine. 2007; 6 (3): 280–283.
   PubMed Web of Science ®Google Scholar
• Tournel G, Becart-Robert A, Courtin P, Hedouin V, Gosset D. Fatal accidental intrathecal injection of vindesine. J Forensic Sci. 2006;51 (5): 1166–1168.
   PubMed Web of Science ®Google Scholar
• Lau G. Accidental intraventricular vincristine administration: an avoid-able iatrogenic death. Med Sci Law. 1996; 36 (3): 263–265.
   PubMed Web of Science ®Google Scholar
• Meggs WJ, Hoffman RS. Fatality resulting from intraventricular vin-cristine administration. J Toxicol Clin Toxicol. 1998; 36 (3): 243–246.
   PubMed Web of Science ®Google Scholar
• Dettmeyer R, Driever F, Becker A, Wiestler OD, Madea B. Fatal myeloencephalopathy due to accidental intrathecal vincristine administra-tion: a report of two cases. Forensic Sci Int. 2001; 122 (1): 60–64.
   PubMed Web of Science ®Google Scholar
• Iqbal Y, Abdullah MF, Tuner C, Al-Sudairy R. Intrathecal vincristine: long-term survivor of potentially fatal chemotherapeutic error. Ann Saudi Med. 2002; 22 (1-2): 108–9.
   PubMed Web of Science ®Google Scholar
• Bleck TP, Jacobsen J. Prolonged survival following the inadvertent in-trathecal administration of vincristine: clinical and electrophysiologic analy-ses. Clin Neuropharmacol. 1991; 14 (5): 457–62.
   PubMed Web of Science ®Google Scholar
• Bain PG, Lantos PL, Djurovic V, West I. Intrathecal vincristine: a fatal chemotherapeutic error with devastating central nervous system effects. J Neurol 1999; 238: 230–234.
   Google Scholar
• Al Fawaz IM. Fatal myeloencephalopathy due to intrathecal vincristine administration. Ann Trop Paediatr. 1992; 12 (3): 339–342.
   PubMed Web of Science ®Google Scholar
• Slyter H, Liwnicz B, Herrick MK, Mason R. Fatal myeloencephalopa-thy caused by intrathecal vincristine. Neurology 1980; 30: 867–871.
   PubMed Web of Science ®Google Scholar
• Al Ferayan A, Russel NA, Al Wohaibi M, Awada A, Scherman B. Cerebrospinal fluid lavage in the treatment of inadvertent intrathecal vin-cristine injection. Childs Nerv Syst 1999; 15: 87–89.
   PubMed Web of Science ®Google Scholar
• Michelagnoli MP, Bailey CC, Wilson I, Livingston J, Kinsey SE. Po-tential salvage therapy for inadvertent intrathecal administration of vin-cristine. Br J Haematol. 1997; 99 (2): 364-7. Erratum in: Br J Haematol 1998;101 (2): 398.
   Google Scholar
• Alcaraz A, Rey C, Concha A, Medina A. Intrathecal vincristine: fatal myeloencephalopathy despite cerebrospinal fluid perfusion. J Toxicol Clin Toxicol. 2002; 40 (5): 557–61.
   PubMed Web of Science ®Google Scholar
• Fernandez CV, Esau R, Hamilton D, Fitzsimmons B, Pritchard S: In-trathecal vincristine: an analysis of reasons for recurrent fatal chemothera-peutic error with recommendations for prevention. J Pediatr Hematol Oncol 1998; 20: 587–590.
   PubMed Web of Science ®Google Scholar
• Gaidys W, Dickerman JD, Walters CL, Young PC. Intrathecal vin-cristine: report of a fatal case despite CNS washout. Cancer 1983; 52: 799–801.
   PubMed Web of Science ®Google Scholar
• Zaragoza MR, Ritchey ML, Walter A. Neurologic consequences of ac-cidental intrathecal vincristine: a case report. Med Pediatr Oncol 1995; 24: 61–62.
   PubMedGoogle Scholar
• Dyke RW. Treatment of inadvertent intrathecal injection of vincristine. N Engl J Med. 1989; 321 (18): 1270–1271.
   PubMed Web of Science ®Google Scholar
• Arid) M, Nespoli L, Porta F, Caselli D, Raiteri E, Burgio GR .Severe acute encephalopathy following inadvertent intrathecal doxorubicin admin-istration. Med Pediatr Oncol. 1990; 18 (3): 261–263.
   PubMedGoogle Scholar
• Jordan B, Pasquier Y, Schnider A. Neurological improvement and rehabilitation potential following toxic myelopathy due to intrathecal injection of doxorubicin. Spinal Cord. 2004; 42: 371–373.
   PubMed Web of Science ®Google Scholar
• Kavan P, Válková J, Kouteck9 J. Management and sequelae after mis-applied intrathecal dactinomycin. Med Pediatr Oncol. 2001; 36 (2): 339–340.
   PubMedGoogle Scholar
• Mortensen ME, Cecalupo AJ, Lo WD, Egorin MJ, Batley R. Inadver-tent intrathecal injection of daunorubicin with fatal outcome. Med Pediatr Oncol. 1992 ;20 (3): 249–253.
   PubMedGoogle Scholar
• Trinkle R, Wu JK. Errors involving pediatric patients receiving chemotherapy: a literature review. Med Pediatr Oncol. 1996; 26 (5): 344–351.
   PubMedGoogle Scholar
• Woods K. The prevention of intrathecal medication errors. London, Department of Health. 2001.
   Google Scholar
• Sanghera N, Chan PY, Khaki ZF, Planner C, Lee KK, Cranswick NE, Wong IC Interventions of hospital pharmacists in improving drug therapy in children: a systematic literature review. Drug Saf. 2006; 29 (11): 1031–1047.
   PubMed Web of Science ®Google Scholar
• Gilbar PJ, Carrington CV. Preventing intrathecal administration of vin-cristine. Med J Aust. 2004;181 (8): 464.
   PubMed Web of Science ®Google Scholar
• Müller T. Typical medication errors in oncology: analysis and preven-tion strategies. Onkologie. 2003; 26 (6): 539–544.
   PubMedGoogle Scholar